Skip to main content

GRANIX

Generic: tbo-filgrastim

Verified·Oct 26, 2026
Manufacturer
Teva
NDC
63459-910
RxCUI
1433768
Route
SUBCUTANEOUS
ICD-10 indication
D70.1

Affordability Check

How much will you actually pay for GRANIX?

In 30 seconds, see every legitimate way to afford GRANIX — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About GRANIX

What is this medication? Granix, which contains the active ingredient tbo-filgrastim, is a prescription medication classified as a leukocyte growth factor. It is primarily used to reduce the duration of severe neutropenia in patients with non-myeloid cancers who are undergoing chemotherapy. Neutropenia is a condition characterized by low levels of neutrophils, which are a type of white blood cell essential for fighting infections. By shortening the time these levels are dangerously low, the medication helps decrease the risk of infection-related complications during cancer treatment.

The medication works by stimulating the bone marrow to produce more neutrophils, thereby boosting the body's immune system defense. It is typically administered via an injection starting shortly after a chemotherapy cycle. Granix is approved for use in both adults and pediatric patients who are at least one month old. It is specifically intended for those receiving myelosuppressive anticancer drugs that are known to cause a significant decrease in white blood cell counts.

Copay & patient assistance

  • Patient Copay Amount: No cost
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Patients must be residents of the United States and meet specific insurance and income criteria; patients may not have an insurance plan or employer involved in alternative funding programs that require application to Teva Cares as a condition for coverage.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How GRANIX appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

12%

671 of 5,499 plans

Most common tier

Tier 5

On 82% of covering formularies

Prior authorization required

93%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)5
8%
Tier 2 (generic)1
2%
Tier 3 (preferred brand)2
3%
Tier 4 (non-preferred brand)3
5%
Tier 5 (specialty)49
82%

Step therapy: 2% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 60 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

Yes——

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.